Characteristics | Total | Mean ± SD / N (%) | P-value | P-value* | |||
---|---|---|---|---|---|---|---|
Q1(< 231 μmol/L) | Q2(231–278 μmol/L) | Q3(278–341 μmol/L) | Q4(> 341 μmol/L) | ||||
N | 1249 | 311 | 311 | 313 | 314 | Â | Â |
BMD, g/cm2 | 0.76 ± 0.14 | 0.71 ± 0.12 | 0.75 ± 0.13 | 0.78 ± 0.14 | 0.80 ± 0.15 |  < 0.001 |  < 0.001 |
Age, y | 67.94 ± 9.61 | 68.28 ± 8.69 | 66.90 ± 9.61 | 67.74 ± 9.31 | 68.83 ± 10.66 | 0.076 | 0.053 |
Platelet count, × 109/L | 185.12 ± 61.04 | 185.08 ± 64.99 | 191.84 ± 58.52 | 181.59 ± 53.16 | 181.98 ± 66.29 | 0.133 | 0.045 |
Neutrophil count, × 109/L | 4.47 ± 2.35 | 4.38 ± 2.12 | 4.51 ± 2.42 | 4.35 ± 2.39 | 4.66 ± 2.44 | 0.355 | 0.206 |
Lymphocyte count, × 109/L | 1.41 ± 0.56 | 1.27 ± 0.50 | 1.40 ± 0.54 | 1.48 ± 0.59 | 1.47 ± 0.58 |  < 0.001 |  < 0.001 |
Monocyte count, × 109/L | 0.41 ± 0.19 | 0.40 ± 0.17 | 0.41 ± 0.18 | 0.40 ± 0.20 | 0.43 ± 0.20 | 0.168 | 0.257 |
Albumin, g/L | 40.26 ± 4.75 | 39.76 ± 4.37 | 40.61 ± 4.65 | 40.58 ± 4.69 | 40.07 ± 5.21 | 0.070 | 0.013 |
Hemoglobin, g/L | 124.20 ± 16.72 | 121.98 ± 18.46 | 125.07 ± 14.24 | 125.26 ± 14.39 | 124.47 ± 19.04 | 0.055 | 0.065 |
Calcium, mmol/L | 2.27 ± 0.18 | 2.24 ± 0.22 | 2.27 ± 0.15 | 2.28 ± 0.13 | 2.28 ± 0.20 | 0.012 |  < 0.001 |
ALT, U/L | 21.14 ± 13.59 | 18.85 ± 10.84 | 20.56 ± 13.62 | 21.04 ± 11.96 | 24.09 ± 16.72 |  < 0.001 |  < 0.001 |
AST, U/L | 23.82 ± 10.68 | 21.99 ± 8.27 | 23.37 ± 9.82 | 23.93 ± 9.93 | 25.96 ± 13.61 |  < 0.001 | 0.002 |
Cr, μmol/L | 61.39 ± 24.98 | 54.87 ± 19.63 | 55.32 ± 12.87 | 60.61 ± 18.73 | 74.66 ± 36.56 |  < 0.001 |  < 0.001 |
CRP, mg/L | 1.66 ± 4.60 | 1.35 ± 3.10 | 1.75 ± 3.56 | 1.51 ± 3.49 | 2.05 ± 7.10 | 0.760 | 0.762 |
BUN, mmol/L | 6.24 ± 1.82 | 5.76 ± 1.45 | 5.83 ± 1.45 | 6.33 ± 1.60 | 7.03 ± 2.33 |  < 0.001 |  < 0.001 |
Glucose, mmol/L | 6.06 ± 1.95 | 6.32 ± 2.14 | 6.12 ± 2.01 | 5.88 ± 1.62 | 5.92 ± 1.96 | 0.019 | 0.041 |
Total cholesterol, mmol/L | 4.58 ± 1.01 | 4.52 ± 1.04 | 4.71 ± 1.05 | 4.54 ± 0.95 | 4.56 ± 0.99 | 0.166 | 0.110 |
Triglyceride, mmol/L | 1.38 ± 0.93 | 1.22 ± 1.12 | 1.30 ± 0.72 | 1.37 ± 0.82 | 1.60 ± 0.98 |  < 0.001 |  < 0.001 |
High-density lipoprotein, mmol/L | 1.46 ± 0.33 | 1.50 ± 0.33 | 1.52 ± 0.33 | 1.45 ± 0.35 | 1.40 ± 0.30 |  < 0.001 |  < 0.001 |
Low-density lipoprotein, mmol/L | 2.74 ± 0.81 | 2.63 ± 0.85 | 2.80 ± 0.79 | 2.71 ± 0.78 | 2.82 ± 0.80 | 0.056 | 0.040 |
Apolipoprotein A, g/L | 1.38 ± 0.27 | 1.38 ± 0.27 | 1.42 ± 0.29 | 1.36 ± 0.27 | 1.35 ± 0.26 | 0.038 | 0.030 |
Apolipoprotein B, g/L | 0.90 ± 0.24 | 0.87 ± 0.25 | 0.92 ± 0.24 | 0.89 ± 0.23 | 0.91 ± 0.23 | 0.085 | 0.076 |
Homocysteine, μmol/L | 13.12 ± 6.80 | 11.34 ± 4.91 | 12.50 ± 7.03 | 12.88 ± 5.46 | 15.44 ± 8.39 |  < 0.001 |  < 0.001 |
25(OH)D levels, ng/mL | 20.81 ± 8.19 | 18.52 ± 7.41 | 21.25 ± 8.20 | 20.89 ± 7.81 | 22.59 ± 8.79 |  < 0.001 |  < 0.001 |
Gender, N (%) |  |  |  |  |  |  < 0.001 | - |
 Male | 233 (18.65%) | 25 (8.04%) | 46 (14.79%) | 64 (20.45%) | 98 (31.21%) |  |  |
 Female | 1016 (81.35%) | 286 (91.96%) | 265 (85.21%) | 249 (79.55%) | 216 (68.79%) |  |  |
BMI categorical, N (%) |  |  |  |  |  |  < 0.001 | - |
  < 24 kg/m2 | 778 (62.29%) | 223 (71.70%) | 206 (66.24%) | 186 (59.42%) | 163 (51.91%) |  |  |
  24–28 kg/m2 | 358 (28.66%) | 75 (24.12%) | 85 (27.33%) | 100 (31.95%) | 98 (31.21%) |  |  |
  ≥ 28 kg/m2 | 113 (9.05%) | 13 (4.18%) | 20 (6.43%) | 27 (8.63%) | 53 (16.88%) |  |  |
CCI score categorical, N (%) | Â | Â | Â | Â | Â | 0.197 | - |
 0 | 879 (70.38%) | 234 (75.24%) | 224 (72.03%) | 209 (66.77%) | 212 (67.52%) |  |  |
 1–2 | 194 (15.53%) | 47 (15.11%) | 39 (12.54%) | 53 (16.93%) | 55 (17.52%) |  |  |
 3–4 | 107 (8.57%) | 17 (5.47%) | 28 (9.00%) | 34 (10.86%) | 28 (8.92%) |  |  |
  ≥ 5 | 69 (5.52%) | 13 (4.18%) | 20 (6.43%) | 17 (5.43%) | 19 (6.05%) |  |  |
Calcitonin usage, N (%) | Â | Â | Â | Â | Â | 0.017 | - |
 No | 973 (77.90%) | 223 (71.70%) | 243 (78.14%) | 254 (81.15%) | 253 (80.57%) |  |  |
 Yes | 276 (22.10%) | 88 (28.30%) | 68 (21.86%) | 59 (18.85%) | 61 (19.43%) |  |  |
Surgery, N (%) |  |  |  |  |  |  < 0.001 | - |
 No | 636 (50.92%) | 119 (38.26%) | 162 (52.09%) | 179 (57.19%) | 176 (56.05%) |  |  |
 Yes | 613 (49.08%) | 192 (61.74%) | 149 (47.91%) | 134 (42.81%) | 138 (43.95%) |  |  |
Primary diagnosis, N (%) |  |  |  |  |  |  < 0.001 | - |
OP without fractures | 771 (61.73%) | 151 (48.55%) | 193 (62.06%) | 213 (68.05%) | 214 (68.15%) | Â | Â |
OPF | 478 (38.27%) | 160 (51.45%) | 118 (37.94%) | 100 (31.95%) | 100 (31.85%) | Â | Â |